(Reuters) - U.S. drugmaker Mylan NV said on Wednesday that U.S. health regulators could not approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug, Advair, and cited "minor deficiencies" with the copycat version.


50


Reuters

Latest News

Los Angeles Times: Philadelphia Phillies are poised to make splash with Bryce Harper or Manny Machado

Los Angeles Times: What we learned in the NHL last week: It's been quite the decline for the Blackhawks

WashingtonPost: ‘There was no Plan B’: Trump scrambles to find chief of staff after top candidate turns him down

USA Today: Zenner a bright spot in Detroit's dull win

USA Today: Horford, Irving, Hayward, Baynes out for Celtics vs Pelicans

USA Today: NASA’s Voyager 2 probe enters interstellar space

Daily Mail: Video: HMS Queen Elizabeth returns to Portsmouth ahead of Christmas

Daily Mail: British Fashion Awards: Kendall Jenner leaves little to the imagination in a sheer gold-beaded dress

FOX: Migrants put US asylum plans on hold as they seek temp jobs in Tijuana

FOX: Migrants put US asylum plans on hold as they seek temp jobs in Tijuana

FOX: Migrants put US asylum plans on hold as they seek temp jobs in Tijuana

CNN: Jailed Huawei exec's bail decision delayed

CBS: "Fortnite" gamer arrested after allegedly assaulting wife on live stream

CTV News: Grammy-nominated violinist James Ehnes credits Manitoba hometown for musical rise

CTV News: City outlines its coyote strategy in hopes of safe coexistence

CTV News: Pilot who targeted main Hydro-Quebec lines gets 7-year sentence

ABC: Canada's Aurora Cannabis buys Mexico's Farmacias Magistrales

Haaretz: Anti-Semites for Zion, then and now

Haaretz: Sara Antoinette, Marie Netanyahu

Haaretz: Evacuate the Hebron settlement now

WashingtonPost: Is the GOP the law and order party? Not so much.

USA Today: Why the Geminid meteor shower will be one of 2018’s best

USA Today: Dog survives California fire, waits weeks for owner's return

14 Related Articles from 2018-06-13